| 1 |
Mobile apps for quick adverse drug reaction report: A scoping review |
|
|
| Edna Ribeiro Parracha, Ana Margarida Advinha, Manuel José Lopes, Sofia Oliveira-Martins |
|
| Pharmacoepidemiology and Drug Safety. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Evolution of adverse drug reactions reporting systems: paper based to software based |
|
|
| M. T. Madhushika, T. P. Weerarathna, P. L. G. C. Liyanage, S. S. Jayasinghe |
|
| European Journal of Clinical Pharmacology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Adverse drug reaction reporting via mobile applications: A narrative review |
|
|
| Dario Leskur, Josko Bozic, Doris Rusic, Ana Seselja Perisin, Tin Cohadzic, Shelly Pranic, Darko Modun, Josipa Bukic |
|
| International Journal of Medical Informatics. 2022; 168: 104895 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 4 |
Pharmacovigilance in low- and middle-income countries: A review with particular focus on Africa |
|
|
| Ronald Kiguba, Sten Olsson, Catriona Waitt |
|
| British Journal of Clinical Pharmacology. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 5 |
Effectiveness of the Med Safety mobile application in improving adverse drug reaction reporting by healthcare professionals in Uganda: a protocol for a pragmatic cluster-randomised controlled trial |
|
|
| Ronald Kiguba, Norah Mwebaza, Ronald Ssenyonga, Helen Byomire Ndagije, Victoria Nambasa, Cordelia Katureebe, Kenneth Katumba, Phil Tregunno, Kendal Harrison, Charles Karamagi, Kathryn A Scott, Munir Pirmohamed |
|
| BMJ Open. 2022; 12(7): e061725 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Smartphone-based mobile applications for adverse drug reactions reporting: global status and country experience |
|
|
| Ayako Fukushima, Noha Iessa, Madhava Ram Balakrishnan, Shanthi Narayan Pal |
|
| BMC Medical Informatics and Decision Making. 2022; 22(1) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 7 |
Mobile app to perform anonymized longitudinal studies in the context of COVID-19 adverse drug reaction monitoring, leveraging the citizenship engagement (Preprint) |
|
|
| Marzia Di Filippo, Alessandro Avellone, Michael Belingheri, Maria Emilia Paladino, Michele Augusto Riva, Antonella Zambon, Dario Pescini |
|
| JMIR Human Factors. 2022; |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 8 |
Adverse event reporting tools and regulatory measures in India through outcome of Pharmacovigilance Programme of India |
|
|
| Jai Prakash, Raghav Sachdeva, TaraniPrakash Shrivastava, CV Jayachandran, Aseem Sahu |
|
| Indian Journal of Pharmacology. 2021; 53(2): 143 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 9 |
Advances in pharmacovigilance in India: Role of mobile application |
|
|
| Rajpushpa Labh, Sachin Gupta, Rachna Gupta |
|
| Indian Journal of Medical Specialities. 2020; 11(3): 124 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 10 |
Impact of educational intervention and reinforcement on adverse drug reporting by nursing students: A prospective follow up study |
|
|
| Manisha Bisht, Puneet Dhamija, Bhomik Goel, Vasantha Kalyani, ShailendraS Handu |
|
| Journal of Public Health and Primary Care. 2020; 1(1): 36 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
